Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA tumor vaccines.

A P Wlazlo1, H C Ertl

  • 1The Wistar Institute, Philadelphia, PA 19104, USA.

Archivum Immunologiae Et Therapiae Experimentalis
|March 27, 2001
PubMed
Summary
This summary is machine-generated.

New nucleic acid vaccines utilize plasmid vectors for high-level antigen expression, stimulating robust immune responses for disease prevention and treatment, including cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Mucosal immunology·2015
Same author

Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Journal of virology·2014
Same author

Protection of non-human primates against rabies with an adenovirus recombinant vaccine.

Virology·2014
Same author

Influenza virus specific CD8⁺ T cells exacerbate infection following high dose influenza challenge of aged mice.

BioMed research international·2013
Same author

CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Journal of virology·2013
Same author

Genetic adjuvants.

Methods in molecular medicine·2011
Same journal

Heteronemin, a Scalarane Sesterterpenoid, Activates Apoptosis and Non-Apoptotic Ferroptosis and Inhibits Cytoprotective Autophagy in Oral Cancer Cells.

Archivum immunologiae et therapiae experimentalis·2026
Same journal

NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation.

Archivum immunologiae et therapiae experimentalis·2026
Same journal

USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity.

Archivum immunologiae et therapiae experimentalis·2026
Same journal

sEV-Enriched Serum Preparations From Healthy Individuals Protect Against Acute Pancreatitis-Induced Intestinal Barrier Dysfunction Through miR-579-3p/ANXA3-Mediated Inhibition of NLRP3 Inflammasome Pyroptosis.

Archivum immunologiae et therapiae experimentalis·2026
Same journal

Herd-Trained Immunity: A Hidden Component of Population-Level Innate Immunity.

Archivum immunologiae et therapiae experimentalis·2026
Same journal

<i>Saccharomyces cerevisiae</i> β-Glucan Training Induces a Nonclassical PGE<sub>2</sub>-<sup>High</sup>/NO-<sup>Low</sup> Macrophage Phenotype in Response to <i>Pseudomonas aeruginosa</i> Exopolysaccharide.

Archivum immunologiae et therapiae experimentalis·2026
See all related articles

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Immunology

Background:

  • Novel vaccines are emerging to combat infectious diseases and cancer.
  • These vaccines leverage plasmid vectors for sustained, high-level expression of target antigens in mammalian cells.

Purpose of the Study:

  • To summarize the development and potential of nucleic acid vaccines.
  • To highlight their mechanisms for inducing comprehensive immune responses.

Main Methods:

  • Utilizing plasmid vectors for antigen expression in mammalian cells.
  • Employing molecular techniques to enhance antigen expression and presentation.
  • Co-expressing genetic adjuvants to broaden immune responses.

Main Results:

Related Experiment Videos

  • Constitutive high-level expression of target antigens is achieved.
  • A full spectrum of immunologic responses, including cell-mediated immunity and antibody production, is induced.
  • Enhanced antigen expression and presentation facilitate more potent immune activation.

    • Conclusions:

    • Nucleic acid vaccines offer a versatile platform for generating potent immune responses.
    • Their ease of generation and effectiveness provide hope for treating and preventing various diseases, particularly cancer.